PALATIN TECHNOLOGIES, INC. Debt Securities, Available-for-sale, Unrealized Loss
PALATIN TECHNOLOGIES, INC. (PTN) reported Debt Securities, Available-for-sale, Unrealized Loss of $590 for the 12-month period ending 2017-06-30, per its 10-K filed 2018-09-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2018-09-13
- PALATIN TECHNOLOGIES, INC. debt securities, available-for-sale, unrealized loss for fiscal 2017 was $590.00, a 69.65% decline from fiscal 2016.
- PALATIN TECHNOLOGIES, INC. debt securities, available-for-sale, unrealized loss for fiscal 2016 was $1.94K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|
| 2017-06-30 | $590.00 10-K · filed 2018-09-13 |
| 2016-06-30 | $1.94K 10-K · filed 2017-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |